Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes
Research output: Contribution to journal › Journal article › Research › peer-review
Original language | English |
---|---|
Journal | Diabetes Care |
Volume | 30 |
Issue number | 6 |
Pages (from-to) | 1608-10 |
Number of pages | 3 |
ISSN | 0149-5992 |
DOIs | |
Publication status | Published - 1 Jun 2007 |
ID: 34070150